Clinical Trial Update: Insulin Glargine in Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on insulin glargine for Type 2 diabetes mellitus. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED